BSX · News · 20261107N
Acquisition / Partnership / Divestiture
BOSTON SCIENTIFIC CORP · 2026-11-07 · Importance 40 · Surprise 42 · In source text
Boston Scientific secured up to US$455 million from Blackstone Life Sciences to co-fund development of its VITALYST heart pump. The reported funding is up to US$455 million; the digest does not specify a funding schedule or other deal terms. The report identifies VITALYST heart pump development as the use of the funds.
Key facts
- Boston Scientific secured up to US$455 million from Blackstone Life Sciences to co-fund development of its VITALYST heart pump. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | committed | +0.4% | Boston Scientific secured up to US$455 million from Blackstone Life Sciences to co-fund development of its VITALYST heart pump. |